The prevalence of diabetes and thyroid related autoantibodies in Sri Lankan children with type 1 diabetes and their unaffected siblings - The utility of a new screening assay

被引:4
作者
Atapattu, Navoda [1 ]
Amoroso, Marie [2 ]
Powell, Michael [2 ]
de Silva, D. G. Harendra [3 ,4 ]
de Silva, K. Shamya H. [3 ,4 ]
Furmaniak, Jadwiga [2 ]
Rees Smith, Bernard [2 ]
Premawardhana, Lakdasa D. [5 ]
机构
[1] Lady Ridgeway Hosp, Endocrinol & Diabet Unit, Colombo, Sri Lanka
[2] RSR Ltd, FIRS Labs, Cardiff, Wales
[3] Lady Ridgeway Hosp, Dept Paediat, Colombo, Sri Lanka
[4] Fac Med, Colombo, Sri Lanka
[5] Cardiff Univ Sch Med, Thyroid Res Grp, Cardiff, Wales
来源
FRONTIERS IN ENDOCRINOLOGY | 2023年 / 14卷
关键词
type; 1; diabetes; GADA; IA-2A; ZnT8A; thyroid autoantibodies; ISLET-CELL; ONSET; IA-2; THYROGLOBULIN; AUTOIMMUNITY; MELLITUS; GAD(65); DISEASE; RISK;
D O I
10.3389/fendo.2023.1028285
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundThere is limited information about diabetes and thyroid related autoantibodies in children with type 1 diabetes (T1D) or their siblings in Sri Lanka. ObjectivesTo assess in T1D children and their unaffected siblings the prevalence of autoantibodies to (1) glutamic acid decarboxylase (GADA), insulinoma associated antigen-2 (IA-2A) and zinc transporter 8 (ZnT8A) using 3 Screen ICA (TM) (3-Screen) and individual ELISA assays; (2) insulin (IAA); and (3) thyroid peroxidase (TPOA), thyroglobulin (TgA) and the TSH receptor (TSHRA). MethodsWe selected - (a) consecutive T1D children, and (b) their unaffected siblings of both sexes, from the T1D Registry at Lady Ridgeway Hospital, Colombo. ResultsThe median age (IQR) of 235 T1D children and 252 unaffected siblings was 11 (8.4, 13.2) and 9 (5.4, 14.9) years respectively, and the duration of T1D was 23 (7, 54) months. (1) T1D children (a) 79.1% were 3-Screen positive; (b) all 3-Screen positives were individual antibody positive (GADA in 74%; IA-2A 31.1%; ZnT8A 38.7%); (c) and were younger (p=0.01 vs 3-Screen negatives); (d) multiple autoantibodies were present in 45.1%; (e) IA-2A (p=0.002) and ZnT8A (p=0.006) prevalence decreased with T1D duration. (f) TPOA and TgA prevalence was higher in T1D children compared to unaffected siblings (28%, p=0.001 and 31%, p=0.004, respectively). (2) Unaffected siblings (a) 6.3% were 3-Screen positive (p=0.001 vs T1D), and 2.4% were positive for IAA; (b) four subjects had two diabetes related autoantibodies, one of whom developed dysglycaemia during follow-up. ConclusionsThe 3-Screen assay, used for the first time in Sri Lankan T1D children and their siblings as a screening tool, shows a high prevalence of T1D related Abs with a high correlation with individual assays, and is also a helpful tool in screening unaffected siblings for future T1D risk. The higher prevalence of thyroid autoantibodies in T1D children is consistent with polyglandular autoimmunity.
引用
收藏
页数:9
相关论文
共 38 条
  • [1] 3 Screen islet cell autoantibody ELISA: A sensitive and specific ELISA for the combined measurement of autoantibodies to GAD65, to IA-2 and to ZnT8
    Amoroso, Marie
    Achenbach, Peter
    Powell, Michael
    Coles, Rebecca
    Chlebowska, Monika
    Carr, Lorraine
    Furmaniak, Jadwiga
    Scholz, Marlon
    Bonifacio, Ezio
    Ziegler, Anette-G
    Smith, Bernard Rees
    [J]. CLINICA CHIMICA ACTA, 2016, 462 : 60 - 64
  • [2] Atapattu N., 2012, Sri Lanka Journal of Diabetes, Endocrinology and Metabolism, V2, P35, DOI DOI 10.4038/SJDEM.V2I1.4333
  • [3] Type 1 diabetes
    Atkinson, Mark A.
    Eisenbarth, George S.
    Michels, Aaron W.
    [J]. LANCET, 2014, 383 (9911) : 69 - 82
  • [4] High frequency of type 1B (idiopathic) diabetes in north Indian children with recent-onset diabetes
    Balasubramanian, K
    Dabadghao, P
    Bhatia, V
    Colman, PG
    Gellert, SA
    Bharadwaj, U
    Agrawal, S
    Shah, N
    Bhatia, E
    [J]. DIABETES CARE, 2003, 26 (09) : 2697 - 2697
  • [5] Basu Madhurima, 2020, Indian J Endocrinol Metab, V24, P256, DOI 10.4103/ijem.IJEM_63_20
  • [6] BEEVER K, 1989, CLIN CHEM, V35, P1949
  • [7] Betterle C., 2019, POLYENDOCRINE DISORD, P1, DOI [10.1007/978-3-319-73082-0_1-1, DOI 10.1007/978-3-319-73082-0_1-1]
  • [8] Birth and coming of age of islet autoantibodies
    Bonifacio, E.
    Achenbach, P.
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2019, 198 (03) : 294 - 305
  • [9] Bossowski A., 2022, CLIN IMMUNOL, V23, P150
  • [10] A sensitive non-isotopic assay for GAD65 autoantibodies
    Brooking, H
    Ananieva-Jordanova, R
    Arnold, C
    Amoroso, M
    Powell, M
    Betterle, C
    Zanchetta, R
    Furmaniak, J
    Smith, BR
    [J]. CLINICA CHIMICA ACTA, 2003, 331 (1-2) : 55 - 59